Global PD-1 and PD-L1 Inhibitors Market Growth 2021-2026

  • receipt Report ID : 157357
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of PD-1 and PD-L1 Inhibitors will have significant change from previous year. By the most conservative estimates of global PD-1 and PD-L1 Inhibitors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 22660 million in 2019. Over the next five years the PD-1 and PD-L1 Inhibitors market will register a 21.0% CAGR in terms of revenue, the global market size will reach US$ 48580 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 and PD-L1 Inhibitors market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

PD-1 Inhibitors

PD-L1 Inhibitors

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Solid Tumors

Blood-related Tumors

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Merck

Bristol-Myers Squibb

Roche

AstraZeneca

Ono Pharmaceutical

Regeneron

Innovent

Hengrui Medicine

Junshi Biosciences

Merck KGaA

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global PD-1 and PD-L1 Inhibitors Consumption 2016-2026

2.1.2 PD-1 and PD-L1 Inhibitors Consumption CAGR by Region

2.2 PD-1 and PD-L1 Inhibitors Segment by Type

2.2.1 PD-1 Inhibitors

2.2.2 PD-L1 Inhibitors

2.3 PD-1 and PD-L1 Inhibitors Sales by Type

2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)

2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Type (2016-2021)

2.3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2016-2021)

2.4 PD-1 and PD-L1 Inhibitors Segment by Application

2.4.1 Solid Tumors

2.4.2 Blood-related Tumors

2.5 PD-1 and PD-L1 Inhibitors Sales by Application

2.5.1 Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2016-2021)

2.5.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Application (2016-2021)

2.5.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2016-2021)

3 Global PD-1 and PD-L1 Inhibitors by Company

3.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company

3.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Company (2019-2021)

3.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2019-2021)

3.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company

3.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Company (2019-2021)

3.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2019-2021)

3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Company

3.4 Global Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Location Distribution

3.4.2 Players PD-1 and PD-L1 Inhibitors Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 PD-1 and PD-L1 Inhibitors by Region

4.1 Global PD-1 and PD-L1 Inhibitors by Region

4.1.1 Global PD-1 and PD-L1 Inhibitors Sales by Region

4.1.2 Global PD-1 and PD-L1 Inhibitors Revenue by Region

4.2 Americas PD-1 and PD-L1 Inhibitors Sales Growth

4.3 APAC PD-1 and PD-L1 Inhibitors Sales Growth

4.4 Europe PD-1 and PD-L1 Inhibitors Sales Growth

4.5 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Growth

5 Americas

5.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country

5.1.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021)

5.1.2 Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021)

5.2 Americas PD-1 and PD-L1 Inhibitors Sales by Type

5.3 Americas PD-1 and PD-L1 Inhibitors Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region

6.1.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region (2016-2021)

6.1.2 APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2016-2021)

6.2 APAC PD-1 and PD-L1 Inhibitors Sales by Type

6.3 APAC PD-1 and PD-L1 Inhibitors Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe PD-1 and PD-L1 Inhibitors by Country

7.1.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021)

7.1.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021)

7.2 Europe PD-1 and PD-L1 Inhibitors Sales by Type

7.3 Europe PD-1 and PD-L1 Inhibitors Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa PD-1 and PD-L1 Inhibitors by Country

8.1.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021)

8.1.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021)

8.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type

8.3 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 PD-1 and PD-L1 Inhibitors Distributors

10.3 PD-1 and PD-L1 Inhibitors Customer

11 Global PD-1 and PD-L1 Inhibitors Market Forecast

11.1 Global PD-1 and PD-L1 Inhibitors Forecast by Region

11.1.1 Global PD-1 and PD-L1 Inhibitors Forecast by Regions (2021-2026)

11.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global PD-1 and PD-L1 Inhibitors Forecast by Type

11.7 Global PD-1 and PD-L1 Inhibitors Forecast by Application

12 Key Players Analysis

12.1 Merck

12.1.1 Merck Merck Company Information

12.1.2 Merck PD-1 and PD-L1 Inhibitors Product Offered

12.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Merck Main Business Overview

12.1.5 Merck Latest Developments

12.2 Bristol-Myers Squibb

12.2.1 Bristol-Myers Squibb Company Information

12.2.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Offered

12.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Bristol-Myers Squibb Main Business Overview

12.2.5 Bristol-Myers Squibb Latest Developments

12.3 Roche

12.3.1 Roche Company Information

12.3.2 Roche PD-1 and PD-L1 Inhibitors Product Offered

12.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Roche Main Business Overview

12.3.5 Roche Latest Developments

12.4 AstraZeneca

12.4.1 AstraZeneca Company Information

12.4.2 AstraZeneca PD-1 and PD-L1 Inhibitors Product Offered

12.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 AstraZeneca Main Business Overview

12.4.5 AstraZeneca Latest Developments

12.5 Ono Pharmaceutical

12.5.1 Ono Pharmaceutical Company Information

12.5.2 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Offered

12.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Ono Pharmaceutical Main Business Overview

12.5.5 Ono Pharmaceutical Latest Developments

12.6 Regeneron

12.6.1 Regeneron Company Information

12.6.2 Regeneron PD-1 and PD-L1 Inhibitors Product Offered

12.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Regeneron Main Business Overview

12.6.5 Regeneron Latest Developments

12.7 Innovent

12.7.1 Innovent Company Information

12.7.2 Innovent PD-1 and PD-L1 Inhibitors Product Offered

12.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Innovent Main Business Overview

12.7.5 Innovent Latest Developments

12.8 Hengrui Medicine

12.8.1 Hengrui Medicine Company Information

12.8.2 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Offered

12.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Hengrui Medicine Main Business Overview

12.8.5 Hengrui Medicine Latest Developments

12.9 Junshi Biosciences

12.9.1 Junshi Biosciences Company Information

12.9.2 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Offered

12.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Junshi Biosciences Main Business Overview

12.9.5 Junshi Biosciences Latest Developments

12.10 Merck KGaA

12.10.1 Merck KGaA Company Information

12.10.2 Merck KGaA PD-1 and PD-L1 Inhibitors Product Offered

12.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Merck KGaA Main Business Overview

12.10.5 Merck KGaA Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. PD-1 and PD-L1 Inhibitors Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of PD-1 Inhibitors

Table 3. Major Players of PD-L1 Inhibitors

Table 4. Global PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)

Table 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 6. Global PD-1 and PD-L1 Inhibitors Revenue by Type (2016-2021) & ($ million)

Table 7. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2016-2021)

Table 8. Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2016-2021)

Table 9. Global PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)

Table 10. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 11. Global PD-1 and PD-L1 Inhibitors Value by Application (2016-2021)

Table 12. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2016-2021)

Table 13. Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2016-2021)

Table 14. Global PD-1 and PD-L1 Inhibitors Sales by Company (2019-2021) & (L)

Table 15. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2019-2021)

Table 16. Global PD-1 and PD-L1 Inhibitors Revenue by Company (2019-2021) ($ Millions)

Table 17. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2019-2021)

Table 18. Global PD-1 and PD-L1 Inhibitors Sale Price by Company (2019-2021)

Table 19. Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution and Sales Area

Table 20. Players PD-1 and PD-L1 Inhibitors Products Offered

Table 21. PD-1 and PD-L1 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global PD-1 and PD-L1 Inhibitors Sales by Region (2016-2021) (L)

Table 25. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2016-2021)

Table 26. Global PD-1 and PD-L1 Inhibitors Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2016-2021)

Table 28. Americas PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021) & (L)

Table 29. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2016-2021)

Table 30. Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)

Table 32. Americas PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)

Table 33. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 34. Americas PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)

Table 35. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 36. APAC PD-1 and PD-L1 Inhibitors Sales by Region (2016-2021) & (L)

Table 37. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2016-2021)

Table 38. APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2016-2021)

Table 40. APAC PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)

Table 41. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 42. APAC PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)

Table 43. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 44. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021) & (L)

Table 45. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2016-2021)

Table 46. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)

Table 48. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)

Table 49. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 50. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)

Table 51. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2016-2021) & (L)

Table 53. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)

Table 57. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)

Table 59. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 60. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2021-2026) & (L)

Table 61. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2021-2026)

Table 62. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 63. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Type (2021-2026)

Table 64. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2021-2026) & (L)

Table 65. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Application (2021-2026)

Table 66. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 67. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Application (2021-2026)

Table 68. Merck Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 69. Merck PD-1 and PD-L1 Inhibitors Product Offered

Table 70. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 71. Merck Main Business

Table 72. Merck Latest Developments

Table 73. Bristol-Myers Squibb Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 74. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Offered

Table 75. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 76. Bristol-Myers Squibb Main Business

Table 77. Bristol-Myers Squibb Latest Developments

Table 78. Roche Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 79. Roche PD-1 and PD-L1 Inhibitors Product Offered

Table 80. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 81. Roche Main Business

Table 82. Roche Latest Developments

Table 83. AstraZeneca Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 84. AstraZeneca PD-1 and PD-L1 Inhibitors Product Offered

Table 85. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 86. AstraZeneca Main Business

Table 87. AstraZeneca Latest Developments

Table 88. Ono Pharmaceutical Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 89. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Offered

Table 90. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 91. Ono Pharmaceutical Main Business

Table 92. Ono Pharmaceutical Latest Developments

Table 93. Regeneron Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 94. Regeneron PD-1 and PD-L1 Inhibitors Product Offered

Table 95. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 96. Regeneron Main Business

Table 97. Regeneron Latest Developments

Table 98. Innovent Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 99. Innovent PD-1 and PD-L1 Inhibitors Product Offered

Table 100. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 101. Innovent Main Business

Table 102. Innovent Latest Developments

Table 103. Hengrui Medicine Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 104. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Offered

Table 105. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 106. Hengrui Medicine Main Business

Table 107. Hengrui Medicine Latest Developments

Table 108. Junshi Biosciences Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 109. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Offered

Table 110. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 111. Junshi Biosciences Main Business

Table 112. Junshi Biosciences Latest Developments

Table 113. Merck KGaA Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 114. Merck KGaA PD-1 and PD-L1 Inhibitors Product Offered

Table 115. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2019-2021E)

Table 116. Merck KGaA Main Business

Table 117. Merck KGaA Latest Developments

List of Figures

Figure 1. Picture of PD-1 and PD-L1 Inhibitors

Figure 2. PD-1 and PD-L1 Inhibitors Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate 2016-2026 (L)

Figure 7. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. PD-1 and PD-L1 Inhibitors Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of PD-1 Inhibitors

Figure 10. Product Picture of PD-L1 Inhibitors

Figure 11. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020

Figure 12. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2016-2021)

Figure 13. PD-1 and PD-L1 Inhibitors Consumed in Solid Tumors

Figure 14. Global PD-1 and PD-L1 Inhibitors Market: Solid Tumors (2016-2021) & (L)

Figure 15. PD-1 and PD-L1 Inhibitors Consumed in Blood-related Tumors

Figure 16. Global PD-1 and PD-L1 Inhibitors Market: Blood-related Tumors (2016-2021) & (L)

Figure 17. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)

Figure 18. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application in 2020

Figure 19. Global PD-1 and PD-L1 Inhibitors Revenue Market by Company in 2020 ($ Million)

Figure 20. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company in 2020

Figure 21. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Regions (2016-2021)

Figure 22. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2020

Figure 23. Americas PD-1 and PD-L1 Inhibitors Sales 2016-2021 (L)

Figure 24. Americas PD-1 and PD-L1 Inhibitors Revenue 2016-2021 ($ Millions)

Figure 25. APAC PD-1 and PD-L1 Inhibitors Sales 2016-2021 (L)

Figure 26. APAC PD-1 and PD-L1 Inhibitors Revenue 2016-2021 ($ Millions)

Figure 27. Europe PD-1 and PD-L1 Inhibitors Sales 2016-2021 (L)

Figure 28. Europe PD-1 and PD-L1 Inhibitors Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales 2016-2021 (L)

Figure 30. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue 2016-2021 ($ Millions)

Figure 31. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2020

Figure 32. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2020

Figure 33. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020

Figure 34. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020

Figure 35. United States PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2020

Figure 40. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Regions in 2020

Figure 41. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020

Figure 42. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020

Figure 43. China PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 47. India PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2020

Figure 50. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2020

Figure 51. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020

Figure 52. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020

Figure 53. Germany PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 54. France PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2020

Figure 59. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020

Figure 61. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020

Figure 62. Egypt PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country PD-1 and PD-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles